Biotime Inc., of Carlsbad, Calif., said it rebranded as Lineage Cell Therapeutics Inc. to better reflect its cell therapy platform. The company's NYSE American ticker changed to LCTX effective at Monday's market opening, with shares dropping 2 cents to close at 90 cents.